ATE366310T1 - Menschliches chondromodulin-i-protein - Google Patents
Menschliches chondromodulin-i-proteinInfo
- Publication number
- ATE366310T1 ATE366310T1 AT94107364T AT94107364T ATE366310T1 AT E366310 T1 ATE366310 T1 AT E366310T1 AT 94107364 T AT94107364 T AT 94107364T AT 94107364 T AT94107364 T AT 94107364T AT E366310 T1 ATE366310 T1 AT E366310T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- chondromodulin
- growth
- transformant
- producing
- Prior art date
Links
- 101000749842 Homo sapiens Leukocyte cell-derived chemotaxin 1 Proteins 0.000 title abstract 2
- 102000052077 human CNMD Human genes 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102400000676 Chondromodulin-1 Human genes 0.000 abstract 3
- 101800004542 Chondromodulin-1 Proteins 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000001612 chondrocyte Anatomy 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 210000003556 vascular endothelial cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10962093 | 1993-05-11 | ||
| JP31829893A JP3585180B2 (ja) | 1993-05-11 | 1993-12-17 | 新規なヒトタンパク質およびそれをコードする遺伝子 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE366310T1 true ATE366310T1 (de) | 2007-07-15 |
Family
ID=26449355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94107364T ATE366310T1 (de) | 1993-05-11 | 1994-05-11 | Menschliches chondromodulin-i-protein |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5719125A (de) |
| EP (1) | EP0624645B1 (de) |
| JP (1) | JP3585180B2 (de) |
| AT (1) | ATE366310T1 (de) |
| CA (1) | CA2122937A1 (de) |
| DE (1) | DE69434997T2 (de) |
| ES (1) | ES2286817T3 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140305A (en) * | 1996-04-04 | 2000-10-31 | Bio-Rad Laboratories, Inc. | Hereditary hemochromatosis gene products |
| US7026116B1 (en) * | 1996-04-04 | 2006-04-11 | Bio-Rad Laboratories, Inc. | Polymorphisms in the region of the human hemochromatosis gene |
| WO1997039116A1 (en) * | 1996-04-12 | 1997-10-23 | Novo Nordisk A/S | Enzyme-containing granules and process for the production thereof |
| US6849399B1 (en) | 1996-05-23 | 2005-02-01 | Bio-Rad Laboratories, Inc. | Methods and compositions for diagnosis and treatment of iron misregulation diseases |
| DE69841593D1 (de) | 1997-06-13 | 2010-05-12 | Bio Rad Laboratories | Verfahren und Zusammensetzungen für die Diagnose und die Behandlung von Krankheiten, die mit Eisenüberschuss oder Eisenmangel assoziiert sind |
| JP2002534972A (ja) * | 1999-01-19 | 2002-10-22 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 33個のヒト分泌タンパク質 |
| EP1219710B1 (de) | 1999-09-29 | 2010-04-07 | Teijin Limited | POLYPEPTIDE UND FüR DIESE KODIERENDE GENE |
| ATE286911T1 (de) * | 1999-11-26 | 2005-01-15 | Takeda Pharmaceutical | Transkriptionsfaktor und dessen dna |
| MXPA02007119A (es) * | 2000-01-19 | 2003-04-14 | Amgen Inc | Peptido relacionado a condromodulina-1. |
| EP1374888A4 (de) * | 2001-02-28 | 2004-07-07 | Mitsubishi Pharma Corp | Heilmittel gegen arthritis deformans und heilmittel gegen rheumatoide arthritis |
| CN1592635A (zh) * | 2001-09-24 | 2005-03-09 | 维里根股份公司 | 自体生长因子鸡尾酒组合物,生产方法以及应用 |
| US8697139B2 (en) | 2004-09-21 | 2014-04-15 | Frank M. Phillips | Method of intervertebral disc treatment using articular chondrocyte cells |
| US20100145441A1 (en) * | 2005-09-22 | 2010-06-10 | Keiichi Fukuda | Therapeutic agents for angiogenesis-related diseases comprising chondromodulin-i as active ingredient |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5444157A (en) * | 1990-08-23 | 1995-08-22 | Mitsubishi Kasei Corporation | Chondromodulin-I protein |
| JPH05178896A (ja) * | 1990-08-23 | 1993-07-20 | Mitsubishi Kasei Corp | 新規なタンパク質、それをコードする遺伝子及びその産生方法 |
-
1993
- 1993-12-17 JP JP31829893A patent/JP3585180B2/ja not_active Expired - Fee Related
-
1994
- 1994-05-05 CA CA002122937A patent/CA2122937A1/en not_active Abandoned
- 1994-05-11 US US08/241,465 patent/US5719125A/en not_active Expired - Lifetime
- 1994-05-11 ES ES94107364T patent/ES2286817T3/es not_active Expired - Lifetime
- 1994-05-11 DE DE69434997T patent/DE69434997T2/de not_active Expired - Lifetime
- 1994-05-11 EP EP94107364A patent/EP0624645B1/de not_active Expired - Lifetime
- 1994-05-11 AT AT94107364T patent/ATE366310T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2122937A1 (en) | 1994-11-12 |
| EP0624645A1 (de) | 1994-11-17 |
| DE69434997T2 (de) | 2008-03-06 |
| DE69434997D1 (de) | 2007-08-16 |
| ES2286817T3 (es) | 2007-12-01 |
| JP3585180B2 (ja) | 2004-11-04 |
| US5719125A (en) | 1998-02-17 |
| JPH07138295A (ja) | 1995-05-30 |
| EP0624645B1 (de) | 2007-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE366310T1 (de) | Menschliches chondromodulin-i-protein | |
| DK0409472T3 (da) | Knoglemorfogenetisk protein | |
| FI880845A0 (fi) | bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi | |
| PT720482E (pt) | Prosaposina e peptidos derivados da citocina utilizados como agentes | |
| ZA909762B (en) | Process for the production of biologically active protein | |
| EP0169016A3 (en) | Polypeptide cartilage-inducing factors found in bone | |
| ES2057544T3 (es) | Composiciones estabilizadas a base de fgf. | |
| IL91691A (en) | T cell growth factor, method for the preparation thereof and pharmaceutical compositions containing the same | |
| DE69120626D1 (de) | Polypeptid | |
| HU895788D0 (en) | Process for producing peptides and medical products containing them | |
| ATE148890T1 (de) | Cyclische peptide mit substance p-und substance k-antagonistischer aktivität | |
| JPS6485079A (en) | Tissue plasminogen activating factor analog having improved proliferating factor domain | |
| DK0523330T3 (da) | Implanterbare sammensætninger indeholdende et biologisk aktivt protein, peptid eller polypeptid | |
| CA2011008A1 (en) | Egf variants and pharmaceutical use thereof | |
| ATE176279T1 (de) | Chondromodulin-i-protein | |
| HUT50195A (en) | New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions | |
| TW221692B (de) | ||
| EP1074264A4 (de) | Inhibitoren für die gefässneubildung | |
| DE69115270D1 (de) | Protein mit fibroblasten-wachstumsfaktor-rezeptoraktivität. | |
| AU6860294A (en) | New chondrocyte proteins | |
| DE69121227D1 (de) | Polypeptid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |